纤维肌痛的药物治疗进展:在地平线上有什么新鲜事?
Piercarlo Sarzi-Puttini1,2, Valeria Giorgi3, Silvia Sirotti1
1Rheumatology Unit, IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Italy.
Expert opinion on pharmacotherapy
|June 10, 2024
概括
纤维肌痛综合征 (FMS) 治疗缺乏确定的药物. 这篇评论分析了已批准的,实验性的和新兴的药物治疗方法,强调了针对性治疗的需要,例如那些解决神经炎症的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 临床试验 临床试验
背景情况:
- 纤维肌痛综合征 (FMS) 是一种慢性疼痛疾病,没有确定的治疗方法.
- 目前的FMS治疗方法往往不够,需要探索新的治疗途径.
研究的目的:
- 系统地审查FMS目前和新兴的药物治疗选择.
- 根据药物的开发阶段,疗效和作用机制来分析药物.
主要方法:
- 在PubMed,谷歌学者和clinicaltrials.gov.gov的综合文献搜索中进行了全面的文献搜索.
- 对FDA批准的药物,非标签药物和研究药物的分析.
- 在特定患者群体中评估药物机制和潜力.
主要成果:
- 对FMS的FDA批准的药物的概述.
- 讨论常用的但在研究中的药物,如阿片类药物和肌肉松剂.
- 评估新兴疗法,包括大麻素和纳尔特雷,以及二期试验中的药物.
结论:
- 症状驱动的,组合治疗对于FMS管理至关重要.
- 对神经炎症,免疫调节和内分泌系统的进一步研究至关重要.
- 将研究结果转化为临床实践是开发向FMS治疗的关键.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
276
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
276
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
Analgesia and Pain Management
579
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
579
Centrally Acting Muscle Relaxants: Therapeutic Uses
668
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
668
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.3K
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42


